Exelon shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced a price target of $46. Also, UBS raised its price target from $40 to $43.
Portfolio Pulse from Benzinga Newsdesk
Exelon shares rise as Jefferies initiates coverage with a Buy rating and a $46 price target. UBS also raises its price target from $40 to $43.
September 20, 2024 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exelon shares are trading higher following positive analyst actions. Jefferies initiated coverage with a Buy rating and a $46 price target, while UBS raised its target from $40 to $43.
The initiation of coverage by Jefferies with a Buy rating and a $46 price target is a strong positive signal for Exelon, likely boosting investor confidence. Additionally, UBS raising its price target from $40 to $43 further supports a positive outlook, contributing to the stock's upward movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100